Showing 231-240 of 333 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Nf2/Merlin Is a Key Mediator of Pancreatic Morphogenesis and Endocrine Differentiation | UT Southwestern | Neha Ahuja | Cures | 01-March-2023 to 28-February-2026 | $214.356,00 |
| Genome-scale CRISPR screens identify ER export cargo proteins as mediators for β-cell stress response and antigen presentation | Indiana Biosciences Research Institute | Isabela Lovizutto Iessi Longo | Cures | 01-March-2023 to 28-February-2026 | $135.307,11 |
| Effects of Volagidemab on Glucagon Rescue from Insulin-Induced Hypoglycemia | REMD Biotherapeutics | Dung Thai | Improving Lives | 30-June-2023 to 29-June-2026 | $672.000,00 |
| Study of ALDH3B2 as a regulator of pancreatic beta cell neogenesis | Joslin Diabetes Center Inc. | Jian Li | Cures | 01-August-2023 to 31-July-2026 | $212.708,89 |
| ROLE OF ZBED3 IN BETA CELL STRESS RESPONSE AND VULNERABILITY AGAINST AUTOIMMUNITY | Indiana Biosciences Research Institute | Erica Cai | Cures | 01-March-2023 to 29-February-2028 | $999.737,71 |
| Using Genome Sequencing and Genetic Risk Scores to Identify Newborns with Serious Health Conditions: A Statewide Implementation Study | RTI International | Curt Scharfe | Cures | 01-December-2022 to 30-November-2025 | $3.356.049,93 |
| Investigating the role of integrated stress response in type 1 diabetes | The University of Chicago | Charanya Muralidharan | Cures | 01-March-2023 to 28-February-2026 | $209.066,00 |
| Clinical Trial Recruitment | T1D Exchange, Inc. | Deborah Taylor | Transportfolio | 01-May-2023 to 30-April-2025 | $264.000,00 |
| Research and Data Research | T1D Exchange, Inc. | Jaime Lucove | Transportfolio | 01-December-2022 to 30-November-2025 | $620.435,07 |
| Development of Low Cost, High Precision Nano Pumps for Insulin Delivery | Torramics Inc. | Sergey Gimelshein | Improving Lives | 01-March-2023 to 31-August-2025 | $1.493.212,43 |